MarketFriction

Bilcare Ltd

NSE BI · BSE 526853 · Healthcare Research, Analytics & Technology
₹96.70 -2.00%
NSE close2026-10-01
52 week range51.62 - 113.00
Market cap₹229 Cr.
P/E11.5
ESM Price band 2%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales190175200194202198194186178181188226
Expenses173158208175194187186175175168171189
Operating Profit1717-8198118113131737
OPM %9%10%-4.1%10%3.8%5%4.0%6%1.9%7%9%16%
Other Income1494-6-621643120
Interest202123212419191919171818
Depreciation10111312111251212554
Profit before tax-13-10-35-10-33-276-13-24-6715
Tax %-5%34%-44%55%-10%-40%-119%-25%-1%3%-13%-1%
Net Profit-12-14-20-15-30-1612-10-23-6815
EPS in Rs-3.22-2.91-4.63-2.71-6.81-3.047.47-1.61-5.250.415.685.39
Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales2,6032,6332,7782,9971,827623845982747788734773
Expenses2,3962,4432,6172,8271,782572784925708742689703
Operating Profit2071901611704551605739464570
OPM %8%7%6%6%2.5%8%7%6%5%6%6%9%
Other Income-8710729759254454423716122620
Interest15117624928317476696082837272
Depreciation16417741637823946393845182026
Profit before tax-194-56-207-433-114-25-4196-72-43-21-7
Tax %-58%42%-4%5%-13%-55%3%74%-18%-35%-19%
Net Profit-82-80-199-453-99-11-450-59-28-17-6
EPS in Rs-36.04-35.91-85.43-193.28-43.97-8.95-5.356.39-14.12-0.330.736.23
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth-12%3%-9%-1%
Compounded Profit Growth-14%16%32%248%
Stock Price CAGR3%7%8%18%
Return on Equity-50%-6%-3%1%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital242424242424242424242424
Reserves1,073689590376-93856352507474191173
Borrowings2,3112,1222,0142,0892,270707677690639756689620
Other Liabilities9337868309138882973003624243142126
Total Liabilities4,3403,6203,4573,4023,0871,1121,0641,1271,5931,568924843
Fixed Assets1,9262,4322,4032,1802,0055344944651,0451,038456432
CWIP2181611491707900111410
Investments01010000281114
Other Assets2,1961,0269041,0511,003577570661545521453387
Total Assets4,3403,6203,4573,4023,0871,1121,0641,1271,5931,568924843
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity-315177300982062567241-76286128
Cash from Investing Activity247-358-129-203-1041,3092-436-10681-5
Cash from Financing Activity119149-15591-103-1,600-83-55-1936-171-132
Net Cash Flow50-3216-13-1-35-9-1810-7-3-10
Free Cash Flow-74-12165-115911,569693711-34142120
CFO/OP-170%85%173%75%148%828%141%78%-6%162%192%283%
Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days1253529383822909570735554
Inventory Days10510884908228908342778086
Days Payable93868110271359310277705770
Cash Conversion Cycle1375732254915887634807869
Working Capital Days1255-11-150-156-2-19-10-1012-528
ROCE %1%2%2%-8%-6%-9%3%3%3%1%4%7%
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters30.01%30.01%30.01%30.01%30.01%30.01%30.01%30.01%30.01%30.01%30.01%30.01%
FIIs0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%0.04%
Public69.94%69.95%69.95%69.95%69.95%69.95%69.95%69.95%69.94%69.95%69.95%69.94%
No. of Shareholders19,87519,18119,11618,78318,24118,49617,58617,04716,51316,06815,82415,777

Fundamentals

Market Cap₹ 229 Cr.
Current Price₹ 101
Stock P/E11.5
Book Value₹ 83.6
ROCE7.06 %
ROE1.39 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)-1%
Compounded Profit Growth (TTM)248%
Consolidated figures.
Valuation
Market capRs 228 Cr
Enterprise valueRs 843 Cr
P/E (TTM)15.51x
Price to book1.16x
Price to sales0.29x
EV / EBITDA9.31x
EV / EBIT13.09x
EV / sales1.09x
Price to cash flow1.78x
Earnings yield6.45%
P/E, 3-year average71.81x
P/B, 3-year average0.64x
P/E, 5-year average39.30x
P/B, 5-year average0.86x
Profitability
Operating margin (excl. other income)6.08%
Operating margin (incl. other income)9.63%
EBITDA margin11.71%
Pre-tax margin-0.97%
Net profit margin1.90%
Net margin, latest quarter5.62%
ROE0.84%
ROCE5.92%
ROA0.20%
ROE, 3-year average-1.95%
ROCE, 3-year average3.48%
ROA, 3-year average-0.66%
ROE, 5-year average-3.29%
ROCE, 5-year average9.08%
ROA, 5-year average-0.40%
ROIC (approx.)6.39%
Tax rate19.44%
Other income / net worth13.23%
Growth
Sales growth (latest year)-6.92%
Sales CAGR, 3 years-9.25%
Sales CAGR, 5 years3.33%
Profit CAGR, 3 years-51.38%
Sales growth QoQ20.36%
Profit growth QoQ-5.01%
Sales growth YoY (latest quarter)21.20%
Per share
EPS (TTM)Rs 6.23
EPS (latest year)Rs 0.73
EPS (latest quarter)Rs 5.39
EPS, 3-year averageRs -4.57
EPS, 5-year averageRs -2.53
Book value per shareRs 83.55
Sales per shareRs 328.32
Cash flow per shareRs 54.28
Free cash flow per shareRs 50.97
Efficiency
Asset turnover0.87x
Fixed asset turnover1.70x
Inventory turnover4.91x
Inventory days74 days
Debtor days54 days
Debtors turnover6.79x
Creditor days70 days
Cash conversion cycle69 days
Working capital days28 days
Leverage
Total debtRs 620 Cr
Cash and bankRs 6 Cr
Net debtRs 615 Cr
Debt to equity3.15x
Net debt / EBITDA6.79x
Interest coverage0.90x
Owners' fund to total sources23.34%
Debt to assets73.61%
Cash flow
Cash from Operating Activity (latest year)Rs 128 Cr
Cash from Investing Activity (latest year)Rs -5 Cr
Cash from Financing Activity (latest year)Rs -132 Cr
Net Cash Flow (latest year)Rs -10 Cr
Free cash flow (latest year)Rs 120 Cr
FCFE (approx.: FCF + change in debt)Rs 51 Cr
Sales to cash flow5.74x
Statement figures
Net sales (TTM)Rs 773 Cr
Net sales (latest year)Rs 734 Cr
Sales (latest quarter)Rs 226 Cr
Operating profit excl. other income (latest year)Rs 45 Cr
Operating profit (latest quarter)Rs 37 Cr
Other income (TTM)Rs 20 Cr
EBITDA (TTM)Rs 91 Cr
PBDT (TTM)Rs 19 Cr
Profit before tax (TTM)Rs -7 Cr
Tax (latest year)Rs -4 Cr
Net profit (TTM)Rs 15 Cr
Net profit (latest year)Rs 2 Cr
Net profit (latest quarter)Rs 13 Cr
Depreciation (TTM)Rs 26 Cr
Depreciation (latest quarter)Rs 4 Cr
Interest (TTM)Rs 72 Cr
Cost of goods sold (latest year)Rs 564 Cr
Total expenditure (latest year)Rs 689 Cr
Total income (latest year)Rs 760 Cr
Share capitalRs 24 Cr
ReservesRs 173 Cr
Shareholders' fundsRs 197 Cr
Total assetsRs 843 Cr
Net blockRs 432 Cr
Capital work in progressRs 10 Cr
InvestmentsRs 14 Cr
ReceivablesRs 108 Cr
InventoryRs 115 Cr
Other liabilitiesRs 26 Cr
Shares outstanding (crore)2.35
Ownership
Promoter holding30.01% (+0.00 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
P/B 1.16 is at the 70th percentile (median 0.66).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
PeriodBINifty 50Difference
1 week-5.9%-2.8% -3.1 pts
1 month+10.8%-6.8% +17.6 pts
3 months+62.1%-7.6% +69.7 pts
3 years+20.1%+14.2% +5.9 pts
5 years+38.7%+27.9% +10.8 pts

Red flags

F-score 8 of 8
seriousLow interest cover Interest cover 0.7x in 2026
lookOn NSE surveillance On NSE surveillance: ESM
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Insider trades

NSE insider and takeover-code disclosures
DateWhoRoleSideSharesValueHow
2026-09-17Guttikonda AnuradhaAcquirerotherSAST Open Market
2026-09-17Guttikonda Vara LakshmiAcquirerbuy312,464SAST Open Market
2026-09-17Guttikonda RajasekharAcquirerbuy160,800SAST Open Market
Latest disclosed trades by insiders, promoters and large holders. Grants, option exercises and pledges show as "other". A filing is a fact, not a signal on its own.

Latest quarter

Jun 2026
Sales ₹226 Cr +21.5% vs Jun 2025. Net profit ₹15 Cr +250.0%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Syngene International Ltd14,82350.09.99 %
Indegene Ltd14,58035.018.8 %
Suven Life Sciences Ltd9,176-79.5 %
Vimta Labs Ltd2,64232.725.2 %
Fabtech Technologies Ltd66113.613.6 %
Take Ltd20835.218.5 %
Novelix Pharmaceuticals Ltd19955.110.9 %
Jeevan Scientific Technology Ltd16346.75.01 %
Adeshwar Meditex Ltd2419.45.21 %
Vanta Bioscience Ltd151331.19 %
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
ESM: stage 2
Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.Updated 2026-10-03